Finance

Beta
Lists
CLYM:NASDAQ
Climb Bio Inc
၁၀.၈၇ US$
-၂.၃၈%
(-၀.၂၇) 1D
ဇွန် ၁၀, GMT-၄ ၁၂:၀၃:၅၆  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLYM...
Open
၁၁.၀၆ US$
High
၁၁.၆၆ US$
Low
၁၀.၆၄ US$
Mkt. cap
၆၁.၃၈ ကုဋေ
Avg. vol.
၁.၁၇ သန်း
Volume
၁.၄၉ သိန်း
52-wk high
၁၂.၄၈ US$
52-wk low
၁.၁၆ US$
EPS
-၀.၇၈ US$
Beta
၀.၁၂
Shares outstanding
၅.၇၃ ကုဋေ
No. of employees
၂၉
Open
၁၁.၀၆ US$
High
၁၁.၆၆ US$
Low
၁၀.၆၄ US$
Mkt. cap
၆၁.၃၈ ကုဋေ
Avg. vol.
၁.၁၇ သန်း
Volume
၁.၄၉ သိန်း
52-wk high
၁၂.၄၈ US$
52-wk low
၁.၁၆ US$
EPS
-၀.၇၈ US$
Beta
၀.၁၂
Shares outstanding
၅.၇၃ ကုဋေ
No. of employees
၂၉
Analyst outlook
Analyst Ratings
Based on 13 analysts giving stock ratings to CLYM in the past 3 months
Strong Buy
Buy
13
Hold
0
Sell
0
12 month forecast
Based on 13 Wall Street analysts offering 12 month price targets for CLYM in the last 3 months.
Highest
Current ၁၀.၈၇ US$
၃၅.၀၀ US$ (+၂၂၁.၉၉%)
Average
၂၂.၄၄ US$ (+၁၀၆.၄၄%)
Lowest
၁၈.၀၀ US$ (+၆၅.၅၉%)
News stories
From sources across the web
TipRanks
TipRanks
·
ပြီးခဲ့သည့် ၁ ရက်
Climb Bio Shareholders Approve Equity Plan Amendment, Reelect Directors
Investing.com
Investing.com
·
ပြီးခဲ့သည့် ၁ ရက်
Climb Bio shareholders elect directors and approve equity plan amendment
Stock Titan
Stock Titan
·
ပြီးခဲ့သည့် ၁ ရက်
Climb Bio (NASDAQ: CLYM) expands equity plan evergreen to cover pre-funded warrants
Investing.com
Investing.com
·
ပြီးခဲ့သည့် ၂ ရက်
Guggenheim initiates Climb Bio stock coverage with buy rating
About Climb Bio Inc
CEO-
Employees၂၉
Founded၂၀၁၈
HeadquartersWellesley Hills, မက်ဆာချူးဆက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၆.၅၈ သန်း
၉.၀၇ သန်း
၁.၃၇ ကုဋေ
၉.၃၇ သန်း
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၄.၁၀ သန်း
၅.၈၂ သန်း
၅.၅၆ သန်း
၅.၈၄ သန်း
Operating expense
၁.၀၇ ကုဋေ
၁.၄၉ ကုဋေ
၁.၉၃ ကုဋေ
၁.၅၂ ကုဋေ
Total operating expenses
၁.၀၇ ကုဋေ
၁.၄၉ ကုဋေ
၁.၉၃ ကုဋေ
၁.၅၂ ကုဋေ
Operating income
-၁.၀၇ ကုဋေ
-၁.၄၉ ကုဋေ
-၁.၉၃ ကုဋေ
-၁.၅၂ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
-၈.၆၇ သန်း
-၁.၂၉ ကုဋေ
-၁.၇၅ ကုဋေ
-၁.၃၇ ကုဋေ
EBT excluding unusual items
-၈.၆၇ သန်း
-၁.၂၉ ကုဋေ
-၁.၇၅ ကုဋေ
-၁.၃၇ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၈.၆၇ သန်း
-၁.၂၉ ကုဋေ
-၁.၇၅ ကုဋေ
-၁.၃၇ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-
-၀.၁၉
-၀.၂၆
-၀.၂၀
Interest and investment income
၂.၁၇ သန်း
၂.၀၄ သန်း
၁.၈၃ သန်း
၁.၅၁ သန်း
Interest expense
-
-
-
-
Net interest expenses
၂.၁၇ သန်း
၂.၀၄ သန်း
၁.၈၃ သန်း
၁.၅၁ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၀၇ ကုဋေ
-၁.၄၉ ကုဋေ
-၁.၉၃ ကုဋေ
-၁.၅၂ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more